Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Psychotherapy for Insomnia in Depression
NCT00149825Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jun 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of escitalopram in major depressive disorder (MDD) and Insomnia (2 arms), sponsored by Stanford University. Primary endpoint: Remission of Depression at 12 weeks. Started Jun 2004; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)Insomnia
Beyond the preview
Go deeper on NCT00149825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149825.